Trial · NCT01012817
Adverse events3,192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 1 | 3 | 3 | 40 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 10 | 6 | 6 | 36 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 11 | 5 | 5 | 22 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 12 | 6 | 7 | 53 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 13 | 3 | 3 | 21 |
| other | Anemia | Blood and lymphatic system disorders | Phase 2 | 21 | 31 | 45 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 2 | 2 | 3 | 5 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 3 | 3 | 3 | 5 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 4 | 4 | 4 | 11 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 5 | 6 | 6 | 112 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 6 | 4 | 7 | 34 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 7 | 2 | 3 | 6 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 8 | 3 | 4 | 33 |
| other | Anemia | Blood and lymphatic system disorders | Phase 1 Dose Level 9 | 1 | 3 | 5 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 1 Dose Level 1 | 0 | 3 | 0 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 1 Dose Level 10 | 4 | 6 | 15 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 1 Dose Level 11 | 2 | 5 | 7 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 1 Dose Level 12 | 0 | 7 | 0 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 1 Dose Level 13 | 1 | 3 | 1 |
| other | Blood and lymph sys disorders - Oth Spec | Blood and lymphatic system disorders | Phase 2 | 1 | 31 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01012817/events